The Pezcoller-Marina Larcher Fogazzaro-EACR Women in Cancer Research Award celebrates the achievements of a cancer researcher who has furthered the advancement of women in cancer research.
The winner gives the prestigious Pezcoller-Marina Larcher Fogazzaro-EACR Women in Cancer Research Award Lecture at the EACR 2022 Congress ‘Innovative Cancer Science: Translating Biology to Medicine’ to be held in Seville, Spain from 20 – 23 June 2022.
The award winner will receive a €10,000 honorarium. As an invited speaker, the award winner will receive a free registration for the EACR Congress plus accommodation and travel costs. They will also be invited to give a lecture in Trento, Italy, at a date to be agreed, for which they will also receive accommodation and travel costs.
We invite the nomination of cancer researchers of any gender who have demonstrated academic excellence and achievements in the field of cancer research and who have, through leadership or by example, furthered the advancement of women in cancer research. Self-nominations cannot be accepted.
Nominees must meet the following criteria:
The nominee should:
Documents to send:
How to submit your nomination
Please email your completed nomination form and accompanying documents as a single pdf to email@example.com.
Deadline for receipt of nominations: 10 January 2022 at 23:59 CET
Professor Karen Vousden received her BSc and PhD in Genetics from Queen Mary College at the University of London working with Lorna Casselton, followed by postdoctoral fellowships with Chris Marshall at the Institute of Cancer Research in London and Douglas Lowy at the National Cancer Institute in the USA. She then became head of the Human Papillomavirus group the Ludwig Institute for Cancer Research in London before moving back to the NCI in 1995, where she was Director of the Molecular Virology and Carcinogenesis Section at the ABL-Basic Research programme and then Chief of the Regulation of Cell Growth Laboratory. In 2002, she returned to the UK to become the Director of the CRUK Beatson Institute in Glasgow, moving back to London in 2016 to take up the role of Chief Scientist at CRUK and Group Leader at the Francis Crick Institute.
Karen's research focuses on the tumour suppressor protein p53, which plays an important role in cancer prevention. Her lab is interested in understanding the signals that induce p53 and the functions of p53 that contribute to its ability to prevent cancer progression. This work has also expanded to encompass an interest in cancer metabolism. Ultimately, the hope is to be able find ways to translate this research for cancer therapy.
Karen has been elected as a Fellow of the Royal Society, the Royal Society of Edinburgh, the Academy of Medical Sciences, EMBO, the European Academy of Sciences, the American Academy of Arts and Sciences, the American Association of Cancer Research Academy and the National Academy of Sciences.
She has also received honorary DScs from the Universities of London and Strathclyde and is an honorary Fellow of the Royal College of Physicians and Surgeons (Glasgow). Karen's awards include the Tenovus Gold Medal, the Sir Frederick Gowland Hopkins Medal, the Royal Medal from the Royal Society of Edinburgh, the Mike Price Gold Medal and she was made a Commander of the British Empire for services to clinical science. She has been on the Board of Directors of the AACR and is a member of the EMBO Council.
The Pezcoller Foundation is a non-profit institution, whose goal is to promote scientific research against diseases which afflict mankind, specifically the fight against cancer. The Founder, Prof. Alessio Pezcoller, was Chief Surgeon at Santa Chiara Hospital in Trento, Italy. The Foundation was established in 1980.
The Foundation depends primarily on the substantial sum of money bequeathed by Professor Alessio Pezcoller, and by significant contributions from its sponsors: the Cassa di Risparmio di Trento e Rovereto Foundation, the Province of Trento, the Administrative Councils of Trento and of Rovereto and other occasional private donations.
Due to its ever increasing recognition within the international oncological community, the Foundation collaborates with some of the most important cancer institutions: the American Association for Cancer Research (AACR) and the European Association for Cancer Research (EACR). The Pezcoller Awards are officially recognised during the international conferences of the two above mentioned associations.
The EACR is grateful for the continued support of its Industry Partners: